Hayden v. 2K Games, Inc. (N.D. Ohio): Won jury trial for 2K Games and its parent company in a lawsuit alleging that they committed copyright infringement by accurately depicting tattoos inked by the plaintiff on certain NBA players in their NBA 2K video game. Prior to the trial, won summary judgment dismissing four tattoos due to knowing inaccuracies in the plaintiff’s copyright registrations. At trial, the jury found after only 90 minutes of deliberation that, when LeBron James was inked, he received a license to be depicted with his tattoos and authorize their depiction as part of his likeness in media.
Teradyne, Inc. v. Astronics Test Systems, Inc. (C.D. Cal./P.T.A.B./9th Cir): Won a complete victory for Astronics Test Systems and its parent company in a patent, copyright, and state law lawsuit concerning aerospace test instruments. Secured dismissal of the copyright claim on summary judgment after the district court found ATS’ copying for compatibility with pre-compiled computer programs was a fair use. The finding of fair use was affirmed on appeal.
In re Certain Prods. Containing Tirzepatide & Prods. Purporting to Contain Tirzepatide (I.T.C.): Won summary determination for Eli Lilly and Company and obtained issuance of a general-exclusion, as well as multiple limited-exclusion orders and cease and desist orders, by the International Trade Commission due to trademark infringement, false designation of origin, and false advertising by sellers and purported sellers of tirzepatide.
Eli Lilly & Co. v. Compounders (D. Az./S.D. Cal./D. Col./D.D.C./M.D. Fla./D. Haw./S.D. Ind./N.D. Ohio/S.D. Ohio/S.D. Tex./W.D. Wash.): Secured permanent injunctions in multiple litigations concerning violations of the Lanham Act and state prohibitions on deceptive trade practices. The cases involve the defendants’ use of Lilly’s MOUNJARO and ZEPBOUND trademarks to market and sell their own, non-FDA approved drugs, as well as promotion of the sale of those drugs by falsely representing them to prospective customers as having the same indicia of safety, effectiveness, and quality as Lilly’s medicines.
